Abstract
Background
In the treatment of pulmonary embolism (PE), the presence of residual emboli is known to seriously affect the recurrence and prognosis. We attempted to depict the residual emboli in the subacute stage of PE using indium-111-oxine labeled platelet scintigraphy (In-plt).
Methods
In-plt was performed on 22 patients with PE who showed an improvement according to lung perfusion scintigraphy. Their accumulation was assessed along with the blood coagulation ability measured on the same day. In addition, radioisotope venography (RI-veno) was performed simultaneously with In-plt to measure the circulatory findings in the lower limb for comparison. All patients received systemic heparin during the acute stage and received warfarin at the time of testing.
Results
Accumulation of In-plt was observed in 7 patients (32%), and positive signals were found in the lower limbs or pelvic cavity in all cases. Two patients were suspected of having poor lower limb circulation from their Rl-veno findings, and these findings were largely consistent with the areas of In-plt accumulation.
Discussion
Some emboli persist after extensive anti-coagulation therapy. The use of In-plt is effective in determining the therapeutic measures and assessing the prognosis as this method allows us to clearly depict the existence of such emboli.
Similar content being viewed by others
Reference
Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study.J Thromb Haemost 2003; 1: 80–87.
Paul AK, Minar E, Christine B, Mirko Hirschl MD, Weltermann A, Eichiger S. The risk of recurrent venous thromboembolism in men and women.New Engl J Med 2004; 350: 2558–2563.
The PIOPED investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of prospective investigation of pulmonary embolism diagnosis (PIOPED).JAMA 1990; 263: 2753–2759.
Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism.Chest 2004; 125: 1539–1545.
Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction.Circulation 2000; 101: 2817–2822.
Hatabu H, Uematsu H, Nguyen B, Miller WT Jr, Hasegawa I, Gefter WB. CT and MR in pulmonary embolism: A changing role for nuclear medicine in diagnostic strategy.Semin Nucl Med 2002; 32: 183–192.
Kearon C, Ginsberg JS, Douketis J, Crowther MA, Turpie AG, Bates SM. A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography.Ann Intern Med 2005; 142: 142–148.
Singh H, Masuda EM. Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux.Ann Vase Surg 2005; 19: 74–79.
Thakur ML, Welch MJ, Joist JH, Coleman RE. Indium-111 labeled platelets: studies on preparation and evaluation ofin vitro andin vivo functions.Thromb Res 1976; 9: 345–352.
Stratton JR, Ritchie JL, Hammermeister KE, Kennedy JW, Hamilton GW. Detection of left ventricular thrombi with radionuclide angiography.Am J Cardiol 1981; 48: 565–572.
Takahashi K, Ohyanagi M, Tateishi J, Masai M, Ikeoka K, Naruse H, et al. Detection of a coronary arterial thrombus by indium-111-oxine-labeled platelet scintigraphy.Ann Nucl Med 2001; 15:49–51.
Kanne JP, Lalani TA. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism.Circulation 2004; 109 (suppl I): I-15–I–21.
Farlow DC, Ezekowitz MD, RamRao S, Denny BD, Morse SS, Decho J, et al. Early imaging acquisition after administration of indium-111 platelets in Clinically Suspected Deep Venous Thrombosis.Am J Cardiol 1989; 64: 363–368.
Honkanen T, Jauhola S, Karppinen K, Paul R, Sakki S, Vorne M. Venous thrombosis: a controlled study on the performance of scintigraphy with Tc99m-HMPAO-la-belled platelets versus venography.Nucl Med Commun 1992; 13:88–94.
Bates SM, Lister-James J, Julian JA, Taillefer R, Moyer BR, Ginsberg JS. Imaging characteristics of a novel technetium Tc99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or history of deep vein thrombosis.Arch Intern Med 2003; 163: 452–456.
Kucher N, Goldhaber SZ. Cardiac biomakers for risk stratification of patients with acute pulmonary embolism.Circulation 2003; 108: 2191–2194.
Kearon C, Ginsberg JS, Michael J, Anderson DR,Wells P, Julian JA. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.N Engl J Med 2003; 349: 631–639.
British Thoracic Society standards of care committee pulmonary embolism guideline development group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.Thorax 2003; 58: 470–484.
Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism.N Engl J Med 2003; 349: 1247–1256.
Worsley DF, Alavi A. Radionucline imaging of acute pulmonary embolism.Semin Nucl Med 2003; 33: 259–278.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, K., Ohnishi, M., Hiromoto, K. et al. Depiction of residual emboli following pulmonary embolism with thrombotic scintigraphy. Ann Nucl Med 19, 641–645 (2005). https://doi.org/10.1007/BF02985111
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02985111